MedPath

Cohort study to investigate the clinical factors associated with the prognosis of high risk myelodysplastic syndrome (MDS) and MDS/secondary AM

Not Applicable
Conditions
High risk myelodysplastic syndrome and MDS/secondary AM
Registration Number
JPRN-C000000399
Lead Sponsor
Japan Adult Leukemia Study Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
250
Inclusion Criteria

Not provided

Exclusion Criteria

none

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy of allo-stem cell transplantation in the survival of high risk MDS and MDS/secondary AM
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath